| Mrs Kelli Holland, ARNP | |
|
1816 Philadelphia St, Ames, IA 50010-8771 | |
| (515) 232-2500 | |
| (515) 246-4479 |
| Full Name | Mrs Kelli Holland |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 10 Years |
| Location | 1816 Philadelphia St, Ames, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548660798 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | A117102 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Unitypoint Health-marshalltown | Marshalltown, IA | Hospital |
| Mercyone Des Moines Medical Center | Des moines, IA | Hospital |
| Mary Greeley Medical Center | Ames, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Catholic Health Initiatives-iowa Corp | 5698683142 | 112 |
News Archive
THERAVECTYS, a clinical development biotechnology company that focuses on the development of therapeutic vaccines and immunotherapies, proudly announces that its manufacturing plant has obtained the status of a pharmaceutical manufacturing establishment, granted by the French National Agency for Medicines and Health Products Safety.
Patients undergoing percutaneous coronary intervention (PCI), a coronary artery widening procedureused to treat heart disease, are at high risk for obstructive sleep apnea (OSA), according to new research presented at the 2015 American Thoracic Society International Conference.
A scalpel-free alternative to brain surgery has the potential to benefit people with Parkinson's disease symptoms that are much more severe on one side of the body, new research suggests.
A novel, accelerator-driven method could produce nuclides for targeted alpha therapy of cancer in practically unlimited amounts, overcoming current obstacles for its wider use due to a limited production of alpha-emitters. The JRC and the Conseil Européen pour la Recherche Nucléaire have embarked to explore the potential of the jointly proposed method.
› Verified 9 days ago
| Entity Name | Catholic Health Initiatives-iowa Corp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508964883 PECOS PAC ID: 5698683142 Enrollment ID: O20031118000163 |
News Archive
THERAVECTYS, a clinical development biotechnology company that focuses on the development of therapeutic vaccines and immunotherapies, proudly announces that its manufacturing plant has obtained the status of a pharmaceutical manufacturing establishment, granted by the French National Agency for Medicines and Health Products Safety.
Patients undergoing percutaneous coronary intervention (PCI), a coronary artery widening procedureused to treat heart disease, are at high risk for obstructive sleep apnea (OSA), according to new research presented at the 2015 American Thoracic Society International Conference.
A scalpel-free alternative to brain surgery has the potential to benefit people with Parkinson's disease symptoms that are much more severe on one side of the body, new research suggests.
A novel, accelerator-driven method could produce nuclides for targeted alpha therapy of cancer in practically unlimited amounts, overcoming current obstacles for its wider use due to a limited production of alpha-emitters. The JRC and the Conseil Européen pour la Recherche Nucléaire have embarked to explore the potential of the jointly proposed method.
› Verified 9 days ago
| Entity Name | Story County Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023080504 PECOS PAC ID: 0547153884 Enrollment ID: O20040204000957 |
News Archive
THERAVECTYS, a clinical development biotechnology company that focuses on the development of therapeutic vaccines and immunotherapies, proudly announces that its manufacturing plant has obtained the status of a pharmaceutical manufacturing establishment, granted by the French National Agency for Medicines and Health Products Safety.
Patients undergoing percutaneous coronary intervention (PCI), a coronary artery widening procedureused to treat heart disease, are at high risk for obstructive sleep apnea (OSA), according to new research presented at the 2015 American Thoracic Society International Conference.
A scalpel-free alternative to brain surgery has the potential to benefit people with Parkinson's disease symptoms that are much more severe on one side of the body, new research suggests.
A novel, accelerator-driven method could produce nuclides for targeted alpha therapy of cancer in practically unlimited amounts, overcoming current obstacles for its wider use due to a limited production of alpha-emitters. The JRC and the Conseil Européen pour la Recherche Nucléaire have embarked to explore the potential of the jointly proposed method.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Kelli Holland, ARNP Po Box 9170, Des Moines, IA 50306-9170 Ph: (515) 633-3600 | Mrs Kelli Holland, ARNP 1816 Philadelphia St, Ames, IA 50010-8771 Ph: (515) 232-2500 |
News Archive
THERAVECTYS, a clinical development biotechnology company that focuses on the development of therapeutic vaccines and immunotherapies, proudly announces that its manufacturing plant has obtained the status of a pharmaceutical manufacturing establishment, granted by the French National Agency for Medicines and Health Products Safety.
Patients undergoing percutaneous coronary intervention (PCI), a coronary artery widening procedureused to treat heart disease, are at high risk for obstructive sleep apnea (OSA), according to new research presented at the 2015 American Thoracic Society International Conference.
A scalpel-free alternative to brain surgery has the potential to benefit people with Parkinson's disease symptoms that are much more severe on one side of the body, new research suggests.
A novel, accelerator-driven method could produce nuclides for targeted alpha therapy of cancer in practically unlimited amounts, overcoming current obstacles for its wider use due to a limited production of alpha-emitters. The JRC and the Conseil Européen pour la Recherche Nucléaire have embarked to explore the potential of the jointly proposed method.
› Verified 9 days ago
Carl Markley, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 420 Kellogg Ave, Ames, IA 50010 Phone: 515-233-3141 | |
Emily Black, ARNP PMHNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 600 5th St, Ames, IA 50010 Phone: 515-233-1122 | |
Alyson Vosberg, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3815 Stange Rd, Ames, IA 50010 Phone: 515-956-4050 | |
Mary Ramen, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: Isu Thomas B. Thielen Student Health Center, Union & Sheldon, Ames, IA 50011 Phone: 515-294-5801 Fax: 515-294-7180 | |
Lindsay Eileen Hannapel, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2530 Chamberlain St, Ames, IA 50014 Phone: 877-849-0763 | |
Marie Burrows, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: Iowa State University, 2260 Thielen Student Health Center, Ames, IA 50011 Phone: 515-294-7265 Fax: 515-294-5457 | |
Jennifer K Britten, A.R.N.P. Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1816 Philadelphia St, Ames, IA 50010 Phone: 515-232-2500 Fax: 515-663-4131 |